» Articles » PMID: 26658303

High-Fat Diet Induced Anxiety and Anhedonia: Impact on Brain Homeostasis and Inflammation

Overview
Date 2015 Dec 15
PMID 26658303
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Depression and type 2 diabetes (T2D) are highly comorbid disorders that carry a large public health burden. However, there is a clear lack of knowledge of the neural pathological pathways underlying these illnesses. The present study aims to elucidate the molecular mechanisms by which a diet rich in fat can cause multiple complications in the brain, thereby affecting intracellular signaling and gene expression that underlie anxiety and depressive behaviors. The results show that a high-fat diet (HFD; ~16 weeks) causes anxiety and anhedonic behaviors. Importantly, the results also show that 4 months of HFD causes disruption of intracellular cascades involved in synaptic plasticity and insulin signaling/glucose homeostasis (ie, Akt, extracellular signal-regulated kinase (ERK), P70S6K), as well as increased corticosterone levels and activation of the innate immune system, including elevation of inflammatory cytokines (ie, IL-6, IL-1β, TNFα). Interestingly, the rapid acting antidepressant ketamine reverses the behavioral deficits caused by HFD and activates ERK and P70S6 kinase signaling in the prefrontal cortex. In addition, we found that pharmacological blockade of the innate immune inflammasome system by repeated administration of an inhibitor of the purinergic P2X7 receptor blocks the anxiety caused by HFD. Together these studies further elucidate the signaling pathways that underlie chronic HFD exposure on anxiety and depressive behaviors, and identify novel therapeutic targets for patients with metabolic disorder or T2D who suffer from anxiety and depression.

Citing Articles

Protective and Therapeutic Effects of Orlistat in Combination with "Cardamom" Extract on Learning, Memory, Anxiety, and Neuroinflammation in Obese Mice.

Al-Dalaeen A, Batarseh N, Abdelhadi N, Atawneh S, AbuKashef R, Al-Yasari A Medicina (Kaunas). 2025; 61(2).

PMID: 40005380 PMC: 11857227. DOI: 10.3390/medicina61020263.


The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms.

Jiao W, Lin J, Deng Y, Ji Y, Liang C, Wei S J Neuroinflammation. 2025; 22(1):10.

PMID: 39828676 PMC: 11743025. DOI: 10.1186/s12974-024-03312-3.


Regular exercise ameliorates high-fat diet-induced depressive-like behaviors by activating hippocampal neuronal autophagy and enhancing synaptic plasticity.

Wu J, Xu H, Wang S, Weng H, Luo Z, Ou G Cell Death Dis. 2024; 15(10):737.

PMID: 39389946 PMC: 11467387. DOI: 10.1038/s41419-024-07132-4.


The Possible Neuroprotective Effect of Caffeic Acid on Cognitive Changes and Anxiety-Like Behavior Occurring in Young Rats Fed on High-Fat Diet and Exposed to Chronic Stress: Role of β-Catenin/GSK-3B Pathway.

El-Sayed N, Khalil N, Saleh S, Aly R, Basta M J Mol Neurosci. 2024; 74(3):61.

PMID: 38954245 DOI: 10.1007/s12031-024-02232-4.


Overweight and Obesity Is Associated with Higher Risk of Perceived Stress and Poor Sleep Quality in Young Adults.

Dakanalis A, Voulgaridou G, Alexatou O, Papadopoulou S, Jacovides C, Pritsa A Medicina (Kaunas). 2024; 60(6).

PMID: 38929600 PMC: 11206025. DOI: 10.3390/medicina60060983.


References
1.
Berman R, Cappiello A, Anand A, Oren D, Heninger G, Charney D . Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000; 47(4):351-4. DOI: 10.1016/s0006-3223(99)00230-9. View

2.
Bjorntorp P, Rosmond R . Obesity and cortisol. Nutrition. 2000; 16(10):924-36. DOI: 10.1016/s0899-9007(00)00422-6. View

3.
Anderson R, Freedland K, Clouse R, Lustman P . The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24(6):1069-78. DOI: 10.2337/diacare.24.6.1069. View

4.
Ahren B, Pacini G . Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. Am J Physiol Endocrinol Metab. 2002; 283(4):E738-44. DOI: 10.1152/ajpendo.00199.2002. View

5.
den Heijer T, Vermeer S, van Dijk E, Prins N, Koudstaal P, Hofman A . Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia. 2003; 46(12):1604-10. DOI: 10.1007/s00125-003-1235-0. View